Free shipping on all orders over $ 500

Carmustine

Cat. No. M3273
Carmustine Structure
Synonym:

NSC-409962

Size Price Availability Quantity
10mM*1mL in DMSO USD 55  USD55 In stock
10mg USD 50  USD50 In stock
50mg USD 95  USD95 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Carmustine (BiCNU) is a cell-cycle phase nonspecific alkylating antineoplastic agent with ED50 ranging from 5.0 µM to 11.9 µM. It is used in the treatment of several types of brain cancer (including glioma, glioblastoma multiforme, medulloblastoma and astrocytoma), multiple myeloma and lymphoma (Hodgkin’s and non-Hodgkin). In a study, three lines with O6-AGT activity below 25 fmol/mg protein had carmustine ED50 values ranging from 5.0 µM to 11.9 µM.

Chemical Information
Molecular Weight 214.05
Formula C5H9Cl2N3O2
CAS Number 154-93-8
Solubility (25°C) DMSO
Storage -20°C, protect from light
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Yun-Dong Zhang, et al. Efficacy and safety of carmustine wafers in the treatment of glioblastoma multiforme: a systematic review

[2] David Y Pereira, et al. Modeling mass transfer from carmustine-loaded polymeric implants for malignant gliomas

[3] Steven H Lin, et al. Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies

[4] Alison B Fleming, et al. Pharmacokinetics of the carmustine implant

[5] N Burnham, et al. BCNU (carmustine)

Related DNA Alkylator/Crosslinker Products
LP-284

LP-284 is a potent DNA alkylating agent that kills solid tumours. LP-284 can be used in the studies of hematologic cancers with compromised DNA repair, such as mantle cell lymphoma (MCL).

4-Hydroperoxy cyclophosphamide

4-Hydroperoxy cyclophosphamide, the active metabolite form of the precursor Cyclophosphamide, cross-links DNA and induces T-cell apoptosis independent of caspase receptor activation, as well as activating the mitochondrial death pathway through the generation of reactive oxygen species (ROS). It can be used in studies related to rheumatoid arthritis and autoimmune diseases.

Diaziquone

Diaziquone is a water-soluble synthetic aziridinyl benzoquinone that selectively alkylates and cross-links DNA, inhibits DNA replication, induces apoptosis, and inhibits the proliferation of tumor cells, with potential antitumor activity.

Semustine

Semustine is a methylated derivative of Carmustine and also a DNA alkylating agent, which can form covalent bonds with nucleophilic centers in DNA, causing depurination, base pair miscoding, strand breaks, and DNA-DNA cross-linking, and has antitumor activity.

Methyl methanesulfonate

Methyl methanesulfonate is a SN2-type alkylating agent that primarily methylates the nitrogen atom in purines and has apoptosis-inducing effects.

  Catalog
Abmole Inhibitor Catalog




Keywords: Carmustine, NSC-409962 supplier, DNA Alkylator/Crosslinker, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.